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Abstract
It has been known for some time that single mutant nude or CD40T mice have apparently normal
numbers of cells in the precursor compartments of bone marrow and the mature B cell
compartments of the periphery. X-linked immunodeficiency (XID) mice are deficient only in some of
the slgM+slgD+ B cells. We have investigated further the contributions of the xid mutation, of the T
cell deficiency of nude and of the inability of CD40T B cells to cooperate with T cells in the
generation of the precursor and the mature B cell compartments in mice. Double mutant XID/nu
and XID/CD40T mice have precursor B cell compartments that are no more deficient than the single
mutant XID mice. However, the peripheral B cell compartments of both XID/nu and XID/CD40T are
even more deficient than those of single mutant XID mice. While 10% of the peripheral B cells of
wild-type or CD40T, one-third of XID and half of XID/nu mice turn over rapidly, as many as three-
quarters of those in XID/CD40T are short-lived. Total numbers of slgM+slgD+ B cells in the spleen
are at best 10-15% of normal mice at 6-8 weeks of age in XID, XID/nu and XID/CD40T mice. They
remain that low at 3 months of age in XID/CD40T mice, while in XID mice these peripheral B cells
slowly build up in numbers with age. As expected, double mutant XID/CD40T mice do not respond
to the T-dependent antigen keyhole limpet hemocyanin. Only the responses to the T-independent
type I antigen, TNP-lipopolysaccharide (LPS), appear to be normal. In vitro, their splenic B cells
respond poorly to LPS or to IgM-specific antibody in either the absence or presence of cytokines.
Most notably, serum IgM, lgG2b and lgG3 levels are severely depressed, while lgG1, lgG2a and IgA
levels are <10 ng/ml. The results suggest a model of mature B cell development in which the
peripheral, mature B cell compartments are generated in two parallel, not tandemly organized
pathways. They could be selected and/or stimulated at the transition from immature to mature B
cells: in btk controlled or in CD40 controlled ways.
Introduction
The discovery of X-linked immunodeficiency (XID) diseases
in humans and mice has demonstrated the existence of
genetic loci on the X chromosome which influences the
growth, differentiation and function of lymphocytes (1-3).
Recently, two groups have isolated the gene encoding a
cytoplasmic tyrosine kinase, named Bruton's tyrosine kinase
(Btk), which in different patients with X-linked agamma-
globulinemia (XLA) appears mutated in different parts of the
gene encoding different domains of the Btk protein (4,5). On
the other hand, one of the best characterized models of this
disease in mice is the CBA/N strain that carries a XID gene
(2). The murine btk gene was mapped to the XID locus of the
murine X chromosome (6,7). A missense mutation, predicted
to alter an amino acid residue (Arg28 to Cys) in the unique
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N-terminal region of the Btk protein, was found in the btk
gene of XID mice, suggesting that this mutant btk gene is
responsible for the XID defect in CBA/N mice (6).
XID mice do not respond to thymus-independent type II
(Tl-ll) antigens (2), respond with a lower number of B cells to
lipopolysaccharide (LPS) (8), do respond to thymus-inde-
pendent type I (Tl-I) antigens and respond normally to thymus-
dependent (TD) antigens (2,9). B cells of XID mice also do
not respond to cross-linking of surface Ig (slg) in the presence
of IL-5 or IL-10 (10,11). Somewhat reduced numbers of
peripheral, mature B cells, and reduced levels of IgM and
lgG3 are found in the XID mice, indicating that the generation
of mature B cells reactive to Tl-I and TD antigens is not
severely affected by the btk mutation.
Thymectomy of CBA/N mice abolishes the ability of these
mice to populate the peripheral lymphoid compartment with
T and B cells, suggesting that at least some of the peripheral
B cells need T cells for their development (12).
In previous studies by Wortis and his colleagues (13), the
XID mutation has been combined with the nude (nu/nu, called
nu herein) defect leading to thymic dysplasia and failure to
develop the a(3 TCR-expressing lineage of T cells. The analysis
of these double mutant XID/nu mice has indicated a more
severe B cell dysplasia, so that B lineage precursor cell
compartments in the bone marrow appeared normal at early
pro/pre-B stages, but depleted of cells expressing IgM either
in the cytoplasm or on their surface. The peripheral, mature
B cell compartments were found severely depleted, incapable
of responding to either Tl or TD antigens. Concomitantly
serum Ig levels were much reduced (12,14-16). The grafting
of thymus into the double mutant XID/nu mice restored
the peripheral mature B lymphoid compartments with cells
capable of responding to Tl and TD antigens (16). Again, this
finding was taken as evidence that some peripheral, mature
B cells are generated in thymus-dependent ways.
CD40 expressed on B cells and its ligand expressed on T
cells control the interactions of helper T cells with B cells and,
thus, responses of B cells to TD antigens which lead to Ig
isotype switching, germinal center formation and induction
of immunological memory (17-24). CD40-deficient (CD40T)
mice, generated by targeted mutation, have peripheral mature
B cells which respond normally to Tl antigens, do respond to
TD antigens with IgM production, but do not respond to TD
antigens with IgG, IgA or IgE production, and do not develop
germinal centers (21). This indicates that the interaction
between CD40 and its ligand is essential for helper T cell-
dependent Ig class switching during responses of B cells to
TD antigens, but is not important for responses to Tl antigens.
Taken together, all these findings suggest that peripheral B
cells can be generated in both btk controlled and CD40
controlled ways.
In this report we further investigate the contributions of the
Xid gene to the nu/nu defect in the primary, B cell generating
compartments of bone marrow. We have also combined the
XID defect effected by the btk mutation with the CD40 defect
in a double mutant mouse strain (called XID/CD40T) to see
whether the inability of B cells to respond to some Tl combined
with the inability to cooperate with helper T cells controls all
of the mature B cell development.
Methods
Mice
CBA/N mice which carry the xid gene were originally obtained
from the Jackson Laboratory (Bar Harbor, ME). In addition, we
also used XID congenic C57BI/6 mice for some experiments.
Athymic C57BI/6 nu/nu mice were originally obtained from
BRL (Fullinsdorf, Switzerland), xid/xid x nu/nu double mutant
mice (called XID/nu in this paper) were generated as
described by Wortis and his colleagues (15). The generation
of CD40T mice has been described elsewhere (21).
Generation of double mutant mice with XID and CD40
deficiency
In order to analyze the effect of a simultaneous abnormality
of XID and CD40 deficiency on B cell development, we bred
double mutant mice from XID and CD40T mice (XID/CD40T
mice). Female CBA/N (xid/xid; homozygous for the mutated
btk gene) mice or female XID congenic C57BI/6 mice (here
called XID) were mated with male CD40T mice (homozygous
for the mutated CD40 gene), followed by mating of the female
F-| mice with male CD40T mice. In the next male offspring,
double mutant XID/CD40T, single mutant CD40T, XID and
wild-type mice were expected and found in a ratio of 1:4 as
described below.
Mice were bled at ages between 10 and 12 weeks to
measure serum Ig levels. To detect the defect of CD40, PCR
analysis was done on DNA from spleen or tail as described
(21). To detect the XID phenotype we analyzed peritoneal
cells by FACS for the absence or presence of CD5+ B cells,
because lack of CD5+ peritoneal B cells is one of the striking
features of XID mice. To confirm the serological typing of XID
mice, PCR analyses was done on DNA from spleen or tail to
detect the btk mutation, using primers and protocols as
described (7).
Antibodies and flow cytometric analysis
FITC-conjugated mAb RA3-6B2 (anti-CD45R, B220), phyco-
erythrin (PE)-conjugated mAb 53-7.3 (anti-CD5), biotinylated
mAb 7D4 (anti-CD25, IL-2R a-chain, TAC) and mAb B3B4
(anti-CD23, IgE Fc receptor) were purchased from Phar-
Mingen (San Diego, CA). mAb ACK4 (anti-c-MQ (25), mAb
M41 (anti-IgM) (26), mAb 1.19 (anti-lgD) (27) and mAb 7E9
(anti-CD21) (28) were purified from culture supernatants
on Protein G-Sepharose (Pharmacia, Uppsala, Sweden) as
recommended by the supplier, followed by conjugation with
biotin according to standard protocols.
Bone marrow, spleen and peritoneal cells were cell surface
stained with antibodies as described elsewhere (29-31), and
stained cells were analyzed by FACScan (Becton-Dickinson,
Mountain View, CA).
Ouantitation of serum Ig levels
Serum IgM, lgG1, lgG2a, lgG2b, lgG3 and IgA levels were
determined by ELISA as described elsewhere (29,31,32).
Goat antibodies specific for mouse Ig classes and subclasses
and mouse Ig standards were purchased from Southern
Biotechnology Associates (Birmingham, AL).
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BrdU labeling of cells
Mice were fed with BrdU (Sigma, St Louis, MO) at 1 mg/ml
in drinking water for 6 days, or for 6 days, followed by a 7
day period of feeding without BrdU (chase) before sacrifice.
Blood, spleen and bone marrow lymphocytes were prepared
in PBS, fixed for 1 h on ice with 0.5% paraformaldehyde in
PBS. Cells were collected by centrifugation and resuspended
in 1 ml of 3N HCI/0.5% Tween 20 and left for 20 min at room
temperature in order to denature DNA. Cells collected by
centrifugation were neutralized by resuspending them in
0.2 ml of 0.1 M borate buffer, pH 8.5, and thereafter adding
1 ml PBS-azide. Cells were washed once, resuspended in
FACS buffer (PBS-azide/2% FCS) and stained with PE-labeled
anti-B220 (PharMingen) and FITC-labeled anti-BrdU (Becton
Dickinson Immunocytometry System, San Jose, CA) followed
by analyses on a FACScan.
Antigens and immunization of mice
For generation of antibody responses to keyhole limpet hemo-
cyanin (KLH), animals were immunized i.p. with 50 ng in
complete Freund's adjuvant. The anti-KLH antibody responses
were measured in sera on day 14 by utilizing a KLH isotype-
specific ELISA (see below).
Primary responses to TNP-LPS were generated by immuniz-
ation with 50 ng TNP-LPS in PBS i.p. The IgM, lgG1, lgG2a
and lgG3 anti-TNP responses were measured in sera on day
14 by a TNP-specific ELISA (see below).
Antigen-specific ELISA
Microtiter plates for ELISA were coated with 10 ng/ml KLH or
5 ng/ml DNP-BSA in PBS overnight at 4°C. They were washed
and blocked with PBS containing 5% FCS and sodium azide.
Diluted serum samples were incubated overnight at 4°C.
Samples were washed and antigen-specific antibody titers
were determined with alkaline phosphatase-conjugated
detection antibodies: goat anti-mouse IgM, lgG1, lgG2a,
lgG2b, lgG3 and IgA (all obtained from Southern Biotech-
nology Associates). After 1 h incubation at 37°C plates were
washed and the ELISA was developed with the substrate
4-nitrophenyl phosphate (1 mg/ml; Sigma) in 1 M diethanol-
amine buffer, pH 9.8. Plates were analyzed on an ELISA
reader (ThermoMax; Molecular Devices, Menlo Park, CA) at
410 and 610 nm. Units represent arbitrary values based on
the titration curve of a standard immune serum from normal
mice according to the procedure described by Foy etal. (19).
Cell culture and in vitro stimulation of spleen cells
Single cell suspensions of spleen from the various mutant
and wild-type mice were prepared and cultured in Iscove's
modified DMEM (Gibco/BRL, Life Technologies, Paisley, UK)
containing antibiotics, 5X10~ 5 M 2-mercaptoethanol and 2%
FCS as described earlier (29). Cultures of 0.2 ml containing
3X105 total spleen cells/ml were set up in 96-well flat-bottom
microtiter ptates and incubated for 3 days at 37°C in a 10%
CO2/air atmosphere. At the onset of culture, various mitogens
and/or recombinant cytokines were added to probe for B cell
proliferative functions. The following mitogens were used: LPS
at 20 |ig/ml (from Escherichia co//EH 100, kindly provided by
Dr C. Galanos, Max Planck Institute for Immunobiology,
Freiburg, Germany), monoclonal anti-CD40 at 10 ng/ml [clone
FGK 45.5 generated as elsewhere (33)], Sepharose-bound
anti-IgM at 1% beads in culture [monoclonal rat anti-mouse
|i-chain, clone M41 (26) bound at 1 mg/ml of packed CNBr-
activated Sepharose 4B (Pharmacia, Uppsala)]. The recom-
binant IL-4 and IL-2 were used at 100 and 1000 U/ml
respectively. They were obtained from a transfected X63-
Ag8.653 cell line (34) generated in our laboratory. Cultures
were pulsed with 1 nCi [3H]thymidine (sp. act. 5 Ci/mmol;
Amersham Life Science, Buckinghamshire, UK) during the
last 4 h of incubation and harvested onto glass fiber paper
which was processed and counted in a Rack-Beta plate
scintillation counter (LKB Pharmacia, Uppsala). Radioactivity
recorded from triplicate cultures was expressed as the mean
c.p.m. per culture. SD between triplicates never exceeded
5% of the mean.
Results
8 lineage precursor cells in the bone marrow of homozygous
wild-type, XID, nu, CD40T, XID/nu and XID/CD40T mice
B220(CD45R)+ B lineage precursors in bone marrow of
different wild-type, mutant and double mutant mice were
analyzed by FACS for the expression of c-kit+, CD25(TAC)+,
slgM+, slgD+ and CD23+ cells. The results of these analyses
are shown in Fig. 1(a and b). The quantities of the different
B-lineage subpopulations are given in Table 1. CD40T and
nude mice have c-kit+ pro/pre-B-l cells, CD25(TAC)+ pre-B-
II cells, slgM+ and CD23+ immature as well as slgD+ mature
B cells in numbers comparable to wild-type mice. XID mice
lack a large part of the slgM+B220 high cells, of the slgD+
cells and of the CD23+ cells, indicating a deficit in the more
mature subpopulations of B cells. XID/nu and XID/CD40T
double mutant mice have normal numbers of c-kit+ pro/pre-
B-l cells. The CD25(TAC)+ pre-B-ll cells and slgM+, slgD+
and CD23+ cells are comparable in both phenotype and
numbers to that of XID single mutant mice in both types of
double mutant mice. The low level of CD23 expression on B
cells of CD40T animals is a consistent finding and has been
reported earlier (21) (also, see below).
We conclude from these analyses that the double expres-
sion of the XID and nu, respectively XID and CD40T mutations,
does not impair B cell development in bone marrow beyond
the defects seen with the single XID mutation. This is in
contrast to previous analyses of XID/nu double mutant mice
performed by Wortis and his colleagues (15).
B lineage cells in the spleen
B220(CD45R)+ B lineage wild-type cells and the different
mutant and double mutant mice were also analyzed in spleen
by FACS for the expression of CD5, slgM, slgD, CD23 and
CD21. These analyses were performed with mice 4-6 weeks
as well as 10-12 weeks of age. The results of these analyses
are shown in Fig. 2, the quantities of the different B-lineage
cell subpopulations are given in Table 2. Wild-type, nu and
CD40T single mutant mice have comparable numbers of
B220+ cells expressing slgM and slgD at both ages. Wild-type
and CD40T single mutant mice have comparable numbers of
CD5+ and CD21+ cells. Consistently, we find that the level of
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CD23 expression is lower in CD40T B cells and thus the
number of detectable CD23+ cells is underscored in such
mice. Spleens of XID/nu and XID/CD40T double mutant mice
at 4-6 weeks of age had slgM+ and slgD+ cells in numbers
slightly less than those of single mutant XID mice. When
the total number of CD45(B220)+ s lg+ cells in spleen was
calculated, seven wild-type mice had an average of 39 ±
5X106 cells, 10 XID mice an average of 9 ± 4X106, six
double mutant CD40T/XID mice an average of 6 ± 1X106
cells and five XID/nu mice an average of 4 ± 2x106 cells
(Table 2). When the same measurements were done with
spleens of 10- to 12-week-old mice, the number of slg+ B
cells had more than doubled in XID mice but remained as
low as in 4- to 6-week-old mice in XID/CD40T mice (Table 2).
We conclude from these data that, in contrast to bone
marrow, the B lineage representation in spleen of XID/nu and
(a) Bone marrow
wt XID CD40T XID/CD40T
6
*
i
»
-I
2.7
0
• it*
27
ft 43,
lTS 1*» t
3.5 3.1
*
-
1
4.0
IP
4.9
3$.'
•3t£-'--. its
* i\i 1^1 if i
IT)
C\J
QO
1
i
0.7
If'
17.2
;A'£&? 32.1
1 * * 1*» 1
i
i
i .
0J
IP
23.2
M>$-- • 24.0
* i4' i t1 ifc* t
V
»
-r
0.6
#
18.2
1
* if i
•
2.1 13.8
, • > • " - : ' • . • •
.+-•«•
'V, */';. 218
a
*1l
0.3
ii
1
 It'
14.5
vfr ' 35.1
S
0.6
*
20.4
'-. Hi.*1'
/ * ' 18.4
1» *
Q
-11
t 26.7 • • • ; . , « *
i
a
i.
i
T
0.4
&1
 ii*
*
 1 6 2
"•W-
% • • 22.2
1«> I** 1
4.9
•IK"'" 29-1
CO
Q
O
X
1
0 J
• I*1
18.6
0
' • •'.-'' •
•CD45R (B220)
Fig. 1. (a) FACS analyses of bone marrow lymphoid cells of wild-type (wt), CD40T, XID and XID/CD40T mice. Horizontal axes represent
fluorescence intensities of CD45R(B220) after surface labeling, while vertical axes represent fluorescence intensities after surface labeling for
c-kit and CD25 (TAC), n (IgM), 8 (IgD) and CD23 as described in Methods.
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XID/CD40T double mutant mice shows a severe reduction in
the numbers of cells expressing different markers associated
with mature B cells. With increasing age this defect remains
severe in the XID/CD40T mice. Our results suggest that the
simultaneous deficiency in the XID and CD40 genes affects
the generation of mature, peripheral B cells at the transition
from the immature bone marrow compartment profoundly and
much more so than does single mutations.
Turnover of peripheral B cells
Mice at 4-6 weeks of age were given BrdU in drinking water
for 6 days, to allow incorporation into DNA of dividing cells
(pulse period). Thereafter, BrdU was removed from the
drinking water for 7 days (chase period) to allow analyses of
the fate of labeled cells. At 6 days after the pulse, and after
7 days of the chase period, B220+ cells in the spleen and
blood were analyzed for BrdU label. The experimental results
(b)
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Fig. 1. (b) FAC5 analyses of bone marrow lymphoid cells of XID, nu and XID/nu mice. Horizontal axes represent fluorescence intensities of
CD45R(B220) after surface labeling, while vertical axes represent fluorescence intensities after surface labeling for c-kit and CD25 (TAC), \i
(IgM) and 8 (IgD).
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Table 1. Total number of B cells in different subpopulationsa in the bone marrow of indicated wild type, single mutant and
double mutant mice
Mouse strain Totalb B220+ B220+/c-/c/f+ B220~7CD25+ B220+/lgM4 B220+/lgD+ B220+/CD23+
Wild-type
CD40T
nu
XID
XID/nu
XID/CD40T
9.2 i
7.9 i
6.8 i
10.2 J
7.3 i
t 0.4
-. 0.7
t 1.2
t 1.5
t 2.3
6.5 ± 1.0
0.5 :
0.6 ;
0.8 :
1.5 :
1.3 :
0.7 :
t 0.2
t 0.1
t 0.4
t 0.6
t 0.5
t 0.3
3.9 :
4.7 i
2.9 :
6.5 :
2.6 :
4.3 :
t 0.4
t 0.1
t 0.5
t 1.5
t 2.0
t 0.2
4.6 ± 0.3
4.3 ± 0.2
2.4 ± 0.5
3.4 ± 0.5
1.8 ± 0.9
2.9 ± 0.9
3.0 ± 0.2
3.3 ± 0.1
2.2 ± 0.2
2.1 ± 0.3
1.5 ± 0.2
1.8 ± 0.6
2.2 ± 0.5
1.7 ±0.6
1.8 ±0.3
0.8 ± 0.1
1.3 ± 0.2
0.4 ± 0.2
aBone marrow of 4- to 6-week-old mice was prepared for FACS analyses as described in Methods. After gating out dead cells, the
percentages of cells within the lymphoid cell gate of which the surface stained for the indicated markers were calculated. The total numbers
of lymphoid cells contained in two femurs from individual mice were counted and they contained 22-26X106 cells. From that number and the
percentage obtained by FACS analyses, the total number of B cells contained in the various fractions was computed. The values given
represent the mean ± SD from four to six individual mice analyzed.
bValues represent number of cells (X106) per two femurs.
for peripheral blood B220+ cells are given in Table 3, since
analyses on splenic B cells gave identical results. The advant-
age of the analyses on blood is that the same animals can
be scored both directly after the pulse of BrdU and then
continuously monitored during the entire chase period. As
expected from previous analyses by other laboratories (35),
wild-type and nu mice had -5-10% of their peripheral B cells
labeled and most of the labeled cells disappeared upon a
chase period of 7 days. This indicates that the labeled cells
are short-lived, while the majority of unlabeled cells should
be longer lived. The same extent of labeling and disappear-
ance upon chase was observed with B lineage cells in CD40T
mice. By contrast, XID mice had a much higher (30-40%)
portion of short-lived cells, while XID/nu double mutant mice
had even higher (-50%) numbers. The highest number of
short-lived cells, i.e. almost three-quarters of all peripheral B
lineage cells, was found in double mutant XID/CD40T mice.
We conclude from these experiments that most of the B cells
generated in XID/CD40T double-deficient mice are and remain
short lived, indicating that long-lived B cells remain few in the
periphery of these mice.
Response of B cells to antigenic stimulation in vivo
KLH was used as a TD antigen and TNP-LPS as a Tl-I antigen
to monitor the in vivo responsiveness of B cells in wild-type,
single mutant CD40T or XID, and double mutant XID/CD40T
mice (Fig. 3a and b). Wild-type and XID mice showed normal
IgM and lgG1 responses to KLH, while CD40T mice, as
expected (21), were 5-fold lower in their IgM responses,
compared to the wild-type mice, and deficient in lgG1
responses. Double mutant XID/CD40T mice showed > 10-fold
reduced IgM responses compared to single mutant CD40T
mice and showed no lgG1 (Fig. 3a), lgG3 or IgA responses
(data not shown) to KLH. Wild-type, single mutant XID as well
as double mutant XID/CD40T mice responded equally well to
the Tl-I antigen TNP-LPS (Fig. 3b)
We conclude that the double mutant XID/CD40T mice are
deficient in TD responses, but do show responses to a
Tl-I antigen.
Responses of peripheral B cells to mitogenic stimulation
in vitro
Spleen cells of wild-type, single mutant CD40T, XID and double
mutant XID/CD40T, varying in B cell content by a factor of 3-5
(see preceding section), were cultured in medium alone, or in
the presence of LPS, of CD40-specific mAb FGK45.5 or of
mouse |iH-chain specific mAb M41 coupled to Sepharose
either alone (Fig. 4a) or in the presence of IL-4 or IL-2 (Fig. 4b).
One of a series of representative experiments is shown. Splenic
B cells from wild-type mice were stimulated by all three B cell
mitogens. The same mitogens also stimulated spleen cells of
XID mice, although -2 - to 4-fold lower responses were consist-
ently recorded in such mass cultures, in the presence or
absence of the cytokines indicated. However, as reported
earlier (8), upon limiting dilution in LPS containing thymus filler
cell cultures (36), spleen cells from XID mice showed 10- to
30-fold lower frequencies of LPS-reactive cells (see legend to
Fig. 4). Spleen cells of CD40T mice were stimulated by LPS
and IgM-specific mAb in the presence and absence of the
cytokines to the same extent as wild-type spleen cells except,
as expected, that the CD40-specific mAb FGK45 did not stimu-
late the CD40-deficient B cells.
In marked contrast, spleen cells of XID/CD40T double
mutant mice showed poor responses to these mitogens, either
in the absence or presence of cytokines.
These results indicate that while single mutant XID or CD40T
B cells retain reactiveness to B cell mitogens, double mutant
XID/CD40T B cells show reactiveness to all mitogens tested
in this study, which are less than proportional to the number
of mature B cells present in their spleens.
Serum levels of Ig classes and subclasses
The sera of wild-type, single and double mutant XID/nu and
XID/CD40T mice at 10-12 weeks of age were analyzed for
their content of IgM, lgG1, lgG2a, lgG2b and lgG3, and,
except for the XID/nu mice, also for their IgA content by
ELISA. The results are summarized in Fig. 5. As expected
(37) XID single mutant mice had lower levels of IgM and
lgG3, and CD40T mice had decreased levels of lgG1 and
IgA; while the other classes and subclasses of Ig were found
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Fig. 2. FACS analysis of splenic lymphoid cells of wild-type (wt), single mutant CD40T mice, and XID mice and double mutant XID/CD40T
mice. Horizontal axes represent fluorescence intensities of CD45R(B220), while vertical axes represent those of CD5, IgM, IgD, CD23 and CD21.
in concentrations comparable to those of wild-type mice. The
double mutant XID/nu mice had depressed levels of IgM,
lgG2a and lgG3. Most notably the double mutant XID/CD40T
had 5- to 10-fold lower levels of IgM, while in >90% of all
mice the lgG1, lgG2a, lgG2b and lgG3 as well as IgA classes
and subclasses were below the detection limit of the assay.
In particular, lgG1, lgG2a and lgG3 subclasses were below
the detection level in all mice tested.
We conclude that the double mutant XID/CD40T mice
show a severe immunodeficiency, manifested in lower or
undetectable serum Ig levels.
Discussion
Single mutant XID, nu or CD40T mice show no severe
deficiencies in the generation of precursor and immature B
cells in the bone marrow, and in the case of CD40T and nu
mice have normal numbers of mature B cells in bone marrow
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Table 2. Total number of B cells in different subpopulationsa in the spleen of indicated wild-type, single mutant and double
mutant mice
Mouse strain
Wild-typec
Wild typed
CD40T
CD40T
nu
XID
XID
XID/nu
XID/CD40T
XID/CD40T
Age (weeks)
4-6
10-12
4-6
10-12
4-6
4-6
10-12
4-6
4-6
10-12
Total5
41.2 :
36.7 :
45.8 :
34.1 :
45.1 :
11.0 :
23.3 :
9.0 :
10.9 :
10.2 :
B220+
t 4.4
t 11.8
t 22.7
t 14.3
t 6.2
t 6.5
t 7.2
t 2.3
t 1.0
t 14.4
B220+/lgM+
38.9 ± 5.3
32.1 ± 15.6
44.5 ± 20.2
35.7 ± 12.2
35.7 ± 5.5
8.8 ± 3.5
20.2 ± 6.0
4.5 ± 1.9
6.1 ±0 .9
8.7 ± 8.9
B220+/lgD+
38.0 ± 5.2
30.7 ± 12.7
44.3 ± 23.1
34.6 ±11.2
37.8 ± 6.2
8.1 ± 4.3
18.9 ± 5.5
3.8 ± 1.2
5.8 ± 1.1
8.5 ± 11.1
B220+/CD23+
32.2 + 6.5
36.7 ± 23.1
18 ± 3.2
31.8 ± 17.2
ND
5.1 ± 1.5
15.4 ± 7.0
ND
2.4 ± 0.9
5.9 ± 6.3
B220+/CD21 +
35.9 ± 5.5
ND
40.2 ± 20.6
ND
ND
4.6 ± 0.4
ND
ND
3.6 ± 0.3
ND
aTotal splenic cells prepared and analyzed by FACS as described in Methods and in the legend of Table 1.
Calculated numbers represent total number of spleen cells (X106). ND, denotes not determined.
cSpleen of the same animals (4-6 weeks old) analyzed for bone marrow B cells in Table 1.
dSpleen of four to 10 individual animals 10-12 weeks old.
and the periphery. In the case of XID and CD40T mice, the
peripheral, mature B cells are not reactive to Tl-ll antigens,
respectively TD antigens, but respond normally to TD, respect-
ively Tl-ll antigens. It is not clear how the peripheral B
cell repertoire of short-lived and long-lived mature, antigen
reactive cells is established. If it was established in ways
comparable to the establishment of the peripheral T cell
repertoire one might expect positive selection of immature
cells through signaling via Ig which could mediate a transition
without division into the mature B cell pool (reviewed in 38,39).
The normal establishment of a peripheral B cell compartment
in the single mutant CD40T and nu mice suggests that such
antigenic selection of the B cell repertoire could occur without
T cells and the interaction of CD40-CD40 ligand, while the
lower number of mature B cells, of which a large fraction is
short lived, in XID mice indicates the involvement of btk
signaling for the generation of long-lived B cells.
Double mutant XID/nu and XID/CD40T mice, again, show
no severe deficiencies in the generation of normal numbers
of precursor and immature B cells in bone marrow but, in
contrast to the single mutant mice, have severe deficiencies
in the mature, peripheral B cell compartments, which in
the case of XID/CD40T mice are very severe. Wortis and
colleagues (15) previously described a severe B cell defect
also in bone marrow of XID/nu mice, which is at variance with
the results described herein. One possible explanation is the
difference in nu/nu strains used for breeding, where we used
C57BI/6 and they used C3H nudes.
We find that double mutant XID/CD40T mice have
decreased numbers of mature B cells, almost three-quarters
of them with a high turnover, and hence show a deficiency in
the generation of long-lived B cells. They have depressed
levels of IgM in the serum, and lack detectable levels of lgG1,
lgG2a, lgG2b, lgG3 and IgA. Furthermore, their B cells cannot
be efficiently stimulated in vivo by TD antigens or in vitro by
a variety of mitogenic stimuli. However, they show responses
to TNP-LPS in vivo, although in vitro responses to LPS are
deficient. It, therefore, appears that B cells are made in
normal numbers in the bone marrow, arrive in the periphery
but cannot be rendered long lived, nor reactive to TD or Tl-ll
Table 3. Percentage of BrdU-labeled peripheral blood B cells
in wild-type, single and double mutant mice
Mouse strain
Wild-type
CD40T
nu
XID
XID/nu
XID/CD40T
BrdU-labeled cells (%)
CD45R(B220)+ cells
After 6 days labeling
10.3 ± 0.4
8.8 ± 0.5
7.0 ± 2.0
38.0 ± 1.7
49.0 ± 3.7
71.5 ± 3.0
of total
After 7 days chase
1.0 ± 0.5
2.0 ± 0.5
2.0 ± 1.2
6.2 ± 6.1
5.2 ± 1.7
4.8 ± 2.0
antigens. The in vivo responses to the Tl TNP-LPS might be
explained if we consider that CBA/N mice have been found
to react to LPS with a 100-fold lower frequency of peripheral
B cells in spleen, but still with a 100-fold higher frequency
than splenic B cells of the LPS non-reactive strain C3H/Hej
(8). In vivo this low but measurable number of reactive B
cells may be sufficient to elicit an antigen-specific response
triggered in association with the mitogen, such as TNP-LPS.
This may also serve as an explanation for the finding here,
that approximately half of the double mutant XID/CD40T mice
have IgM levels >10 ^g/ml and in some cases at almost
normal levels, approaching 100 ng/ml (Fig. 5).
The number of peripheral, mature B cells differs by factors
of 5-10 in individual XID/CD40T mice. Such fluctuations in
the number of peripheral B cells might either be due to a
difference in the genetic background of the mice or have
epigenetic causes. It should be remembered that the XID/
CD40T double mutant mice were generated by mating
CBA/N with CD40T mice, the latter being a mix of the strains
C57BL/6 and 129. Hence, three different genotypes are mixed
in various proportions in individual XID/CD40T mice. It remains
to be investigated how such different genetic backgrounds
could influence the number of short-lived and long-lived
peripheral B cells.
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D I9M antl-KLH
• IgG, antl-KLH
wt XID CD40T XID/
C040T
CD40T
XID/CD40T
Q IgM anti-TNP
• lgG1 anti-TNP
0 lgG2 a anti-TNP
S lgG3 anti-TNP
XID CD40T XID/
Fig. 3. (a) Antibody responses to KLH of wild-type, single mutant
CD40T and XID, and double mutant XID/CD40T mice. Mice were
immunized with KLH in complete Freunds adjuvant (50 ng/mouse,
i.p.) and the KLH-specific serum antibody titers of IgM (open bars)
and lgG1 (filled bars) were determined on day 14 after immunization
by a KLH-specific ELISA (see Methods). Units represent arbitrary
values based on the titration curve of a standard immune serum
according to Foy et al. (19). The means of titers from three mice per
group are shown, (b) Single mutant XID and double mutant XID/
CD40T mice were immunized with TNP-LPS (50 u.g/mouse, i.p.). On
day 14, mice were bled and the anti-TNP antibody titer of IgM (open
bars), lgG1 (filled bars), lgG2a (light shaded bars) and lgG3 (dark
shaded bars) type were determined by ELISA as described in
Methods. Units represent arbitrary values based on the titration curve
of a standard immune serum. The responses in wild-type and CD40T
mice were similar to those of the XID and XID/CD40T [ND; data not
shown, but given elsewhere (21)].
Anti-lg Sepharose®
* IL-2
XID/CD40T
0 2 4 6
3H-TdR uptake on day 2 of culture
(com y 10'4 cer 2 y 105 cu'tu-od cells)
Fig. 4. Proliferative responses of wild-type, single mutant CD40T and
XID, and double mutant XID/CD40T mice stimulated by various B
cell mitogens (as described in Methods) in the absence (a) and
presence (b) of cytokines. In parallel experiments the frequency of
LPS-reactive cells was determined in limiting dilution analyses using
rat thymus filler cells (36). The frequency of LPS-reactive cells
developing into clones of IgM-secreting cells were 1:12 for wt, 1:3
for CD40T, 1:100 for XID and < 1:1000 for XID/CD40T mice.
On the other hand, it is also possible that epigenetic
influences, such as antigenic stimulation, could influence the
level of short- and long-lived B cells in the periphery. This
could either occur at the mature, resting B cell stage in the
periphery or at the transition from immature to mature B cells
in the bone marrow. If it were antigenic stimulation, it would
have to be of a type which mediates its effects by ways
different from those used by Tl-ll or TD antigens used in our
experiments. In fact, a Tl-I antigen might be a good candidate
for such B cell stimulation. Influence of antigen on the
development of peripheral B cells could also occur at an
earlier stage. Recent experiments with Ig transgenic mice on
a rearrangement-deficient (RAG-1T and RAG-2T) genetic
background have shown that B cell development is arrested
at the stage of an immature, slg+ B cell in the bone marrow,
provided that the transgenic Ig recognizes an autoantigen
expressed in bone marrow (40,41). In the case of the TNP-
specific Sp6 Ig transgene, arrest is likely to be mediated by
double-stranded DNA present in bone marrow. It was found
that injection of TNP-Ficoll, a Tl-ll antigen cross-reactive with
DNA, relieved this arrest of differentiation, so that B cells
appeared in the periphery and could be stimulated to a
response, with the development of transgenic Ig-secreting
plasma cells (41).
The severely impaired establishment of the peripheral,
mature B cell compartment(s) in the double mutant XID/
CD40T mice suggests that CD40-dependent and W/c-depend-
ent ways of selection and/or stimulation of immature and/or
mature B cells could control the generation and maintenance
of normally-sized mature B cell pools. The fact that XID/nu
mice, although deficient in the generation of mature B cells,
can generate a peripheral B cell pool of which a considerably
larger part is long-lived compared to that of XID/CD40T mice
and the finding that slg+ B cells do accumulate with age in
the periphery of XID, but not of XID/CD40T mice might indicate
that extrathymic components such as y5 TCR-expressing T
cells might directly or indirectly contribute to this build up of
a peripheral B cell pool. The btk gene and the CD40 ligand-
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Fig. 5. Serum Ig levels of wild-type, single mutant CD40T and XID, and double mutant XID/CD40T and XID/nu mice. The serum levels of IgM,
lgG1, lgG2a, lgG2b and lgG3 of individual wild-type (denoted W and crosses), CD40T (denoted 40 and filled circles); XID (denoted X and
open circles), nu (denoted nu and filled diamonds), XID/nu (denoted nuX and open diamonds) and XID/CD40T (denoted 40X and filled
squares) mice are given. Values <10 ng/ml are placed at the bottom. Serum levels of IgA were not determined in nu and XID/nu mice. Wild-
type mice represent values of serum Ig levels in C57BL/6 mice and in mice of other genetic backgrounds which were pooled in this figure,
since they did not significantly differ from each other.
CD40 interaction between helper T cells and B cells appear
to control all of the detectable mature, long-lived B cell pools,
and appear to do so in parallel and not in tandem. It remains
remarkable that the toWc-mutation alone is relatively mild (XID)
in mice, but severe (XLA) in man. This might suggest that
man generate peripheral B cell pools, much more so than
mice, in a £>f/<-dependent rather than in a CD40-dependent
way.
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